Brief: Cereno Scientific Secures SEK 100 Mln Through Loan Financing, Conversion To Advance HDAC Inhibitors
20/06/2025 07:57
June 20 (Reuters) - Cereno Scientific AB CRNOSb.ST: SECURES 100 MSEK THROUGH ADDITIONAL LOAN FINANCING AND CONVERSION TO ADVANCE HDAC INHIBITORS CS1 AND CS014 IN PHASE II Source text: ID:nWkr9xpYNt Further company coverage: [CRNOSb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln